Ironwood Pharmaceuticals (IRWD) vs Inventiva S.A. American Depository Shares (IVA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Ironwood Pharmaceuticals (IRWD) has outperformed Inventiva S.A. American Depository Shares (IVA) over the past year, gaining 48.7% versus a loss of 27.0%. Over five years, IRWD leads with a -57.9% price change compared with -76.5% for IVA. Ironwood Pharmaceuticals is the larger company by market cap ($778.1 million vs $750.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IRWD | IVA |
|---|---|---|
| Share price | $4.70 | $3.14 |
| Market cap | $778.09M | $750.78M |
| 1-day change | -0.21% | -8.99% |
| YTD return | +39.47% | -32.47% |
| 1-year return | +48.73% | -26.98% |
| 5-year return | -57.89% | -76.53% |
| P/E ratio (TTM) | 5.22 | — |
| Forward P/E | 3.00 | — |
| EPS (TTM) | $0.90 | $-0.62 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $296.15M | — |
| Revenue growth (YoY) | -15.72% | — |
| Net income (latest FY) | $24.02M | $-49.63M |
| Operating margin | 33.26% | — |
| Net margin | 8.11% | — |
| 52-week high | $5.78 | $7.29 |
| 52-week low | $2.95 | $2.82 |
| Distance from 52-week high | -18.69% | -56.93% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +31.49% | +359.24% |
| Average volume | 2.15M | 2.40M |
| Shares outstanding | 165.55M | 239.10M |
| Employees | 100 | 87 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IRWD has outperformed IVA by 75.7 percentage points over the past year.
About Ironwood Pharmaceuticals
IRWD stock →Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It sells linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation, as well as for pediatric patients suffering from functional constipation under the LINZESS and CONSTELLA names.
Health Care · Biotechnology: Pharmaceutical Preparations · 100 employees
About Inventiva S.A. American Depository Shares
IVA stock →Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses.
Health Care · Biotechnology: Pharmaceutical Preparations · 87 employees
IRWD vs IVA FAQ
Which is bigger, Ironwood Pharmaceuticals or Inventiva S.A. American Depository Shares?
Ironwood Pharmaceuticals (IRWD) is larger, with a market capitalization of $778.09M compared with $750.78M for Inventiva S.A. American Depository Shares (IVA).
Which stock has performed better over the past year, IRWD or IVA?
IRWD returned +48.73% over the past 12 months, compared with -26.98% for IVA (price return, excluding dividends). Past performance does not predict future results.
Are Ironwood Pharmaceuticals and Inventiva S.A. American Depository Shares in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.